HUM vs PAHC · P/E 39, rev $129.66B vs P/E 13, rev $1.30B
Humana Inc (HUM) versus Phibro Animal Health Corporation (PAHC) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported PAHC revenue for 2025-06-30 was $1.30B. Net income was $48.3M. Revenue was up 27.4% from 2024-06-30 to 2025-06-30. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
Not investment advice. Open the HUM and PAHC stock pages for the full models.
Not investment advice.